Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Solid Tumor 1

Interventions

Fluorodeoxyglucose F18 2toripalimab 1spartalizumab 1sintilimab 1osimertinib 1olaparib 1apatinib 1Ink 1Histocompatibility Testing 1Carboplatin 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Solid Tumor × Ink × Clear all
NCT06245018 2024-02-07

A Trial to Evaluate the Safety and Preliminary Efficacy of iNK in the Treatment of Subjects With Solid Tumor

Nuwacell Biotechnologies Co., Ltd.

Phase NA Not yet recruiting
50 enrolled
Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡